Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Glycyrrhiza uralensis extract (also known as Chinese licorice extract) is a botanical extract derived from the roots and rhizomes of *Glycyrrhiza uralensis*. It is widely used in traditional Chinese medicine and has been investigated in modern research for its anti-inflammatory, antioxidant, antiviral, and hepatoprotective properties. The extract contains several bioactive constituents, including triterpenoid saponins (such as glycyrrhizin and glycyrrhetinic acid) and flavonoids (such as liquiritin, liquiritigenin, and isoliquiritigenin). It has been studied in clinical and preclinical settings for various indications, including dental caries, periodontal disease, halitosis, chronic obstructive pulmonary disease (COPD), rotavirus-induced gastroenteritis, and COVID-19. Its mechanisms of action involve the activation of the Nrf2 pathway, inhibition of NF-κB transactivation, and inhibition of aromatase activity.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on glycyrrhiza uralensis extract.